Emerging Approaches in AMD and DME: A Case-Based Discussion : Episode 3

Single-dose faricimab in treatment-experiences eyes with nARMD: Case 2

October 11, 2023

Moritz Pettenkofer, MD

Commentary

Video

Moritz Pettenkofer, MD, presents a case of a 75-year-old male patient with nARMD who has had 53 injections of anti-VEGF therapy over 4 years.

EP: 1.Overview of Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema

EP: 2.Single-dose faricimab in treatment-experiences eyes with nARMD: Case 1

EP: 3.Single-dose faricimab in treatment-experiences eyes with nARMD: Case 2

Related Videos

Cindy X. Cai, MD: Impact of Race, Neighborhood on Diabetic Retinopathy Care | Image Credit: Johns Hopkins University

Dimitra Skondra, MD, PhD: Protective Effect of Metformin in Geographic Atrophy| Image Credit: University of Chicago

Deepak Sambhara, MD | Image Credit: American Society of Retina Specialists

Sean Adrean, MD: Impact of Baseline VA on Aflibercept 8 mg Outcomes in DME | Image Credit: Linkedin

Mark Barakat, MD: Stable IOP Outcomes After Aflibercept 8 mg in DME | Image Credit: Retina Macula Institute of Arizona

Roger Goldberg, MD: Impact of Dual Inhibition on Hard Exudates in DME | Image Credit: Bay Area Retina Associates

Deepayan Kar, PhD, MS: A Virtual Reality Approach to Contrast Sensitivity in AMD | Image Credit: LinkedIn

Dolly Chang, MD, PhD | Image Credit: LinkedIn

Daniel Su, MD: | Image Credit: Retina Vitreous-Associates Medical Group

Daniela Ferrara, MD, PhD: Machine Learning Predicts Functional Outcomes in DME | Image Credit: Ophthalmology Innovation Summit

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences

All rights reserved.